89.2
RedHill Biopharma Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
85.9
FY23:
16.1
FY24:
11.9
FY25:
6.53
(positive)
Change from FY21 to FY25
millions USD
FY21:
92.0
FY22:
73.0
FY23:
6.91
FY24:
6.13
FY25:
18.8
Total assets
Change from FY21 to FY25
millions USD
FY21:
181
FY22:
159
FY23:
23.0
FY24:
18.0
FY25:
25.3
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
81.5
FY22:
197
FY23:
20.0
FY24:
22.2
FY25:
19.2
(negative)
Change from FY21 to FY25
millions USD
FY21:
90.8
FY22:
9.82
FY23:
1.00
FY24:
0.50
FY25:
1.86
(positive)
Change from FY21 to FY25
millions USD
FY21:
8.88
FY22:
−48.4
FY23:
2.07
FY24:
−4.68
FY25:
4.27
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
181
FY22:
159
FY23:
23.0
FY24:
18.0
FY25:
25.3
All amounts in millions USD